BRIAN MCGOVERN, M.B.; HASAN GARAN, M.D.; JEREMY N. RUSKIN, M.D.
This content is PDF only. Please click on the PDF icon to access.
Various innovative drug, surgical, and electrical treatments have been used recently for patients with ventricular tachyarrhythmias (1-8). Each approach has enthusiastic advocates who compare studies and attribute fewer recurrent arrhythmias or improved survival to a particular treatment. However, no adequate comparative studies between these therapies have been done. Furthermore, because of ethical and practical constraints, randomized placebo-controlled studies that may approximate an ideal comparison may never be done for some of these therapies (9). Because of reports of promising, albeit uncontrolled, data, many physicians are understandably reluctant to withhold a particular treatment from a patient considered to be at high
MCGOVERN B, GARAN H, RUSKIN JN. Treatment of Ventricular Arrhythmias—Suppression, Survival, and the Problem of Bias. Ann Intern Med. ;101:123–125. doi: 10.7326/0003-4819-101-1-123
Download citation file:
Published: Ann Intern Med. 1984;101(1):123-125.
Cardiology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use